Cargando…
DRUG THERAPY IN KNEE OSTEOARTHROSIS
Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ tre...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783603/ https://www.ncbi.nlm.nih.gov/pubmed/26998447 http://dx.doi.org/10.1016/S2255-4971(15)30043-4 |
_version_ | 1782420140204228608 |
---|---|
author | de Rezende, Márcia Uchôa Gobbi, Riccardo Gomes |
author_facet | de Rezende, Márcia Uchôa Gobbi, Riccardo Gomes |
author_sort | de Rezende, Márcia Uchôa |
collection | PubMed |
description | Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ treatment, some are basically analgesics and do not interfere on disease’s progression; some are anti-inflammatory with good analgesic power but with side effects that compromise their prolonged usage; and the structure modifying drugs that slow down the progression of OA. The medications are presented in topic, oral, intra-muscular, intra-venous and intra-articular forms. The hyaluronic acid has various presentations with good analgesic effect and some evidence of structure modifying property. There is IA evidence level for the use of diacerhein and of glucosamine to slow down the disease. Still, more technology for diagnosis and therapy control of OA is necessary to define the efficacy of other drugs. |
format | Online Article Text |
id | pubmed-4783603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-47836032016-03-18 DRUG THERAPY IN KNEE OSTEOARTHROSIS de Rezende, Márcia Uchôa Gobbi, Riccardo Gomes Rev Bras Ortop Updating Article Clinical treatment for osteoarthritis (OA) is very important and is based on patient’s self care and guided by the physician. Drug therapy is additional to losing weight, improving muscular strength, proprioception, flexibility and range of motion. Between the available drugs for osteoarthritis’ treatment, some are basically analgesics and do not interfere on disease’s progression; some are anti-inflammatory with good analgesic power but with side effects that compromise their prolonged usage; and the structure modifying drugs that slow down the progression of OA. The medications are presented in topic, oral, intra-muscular, intra-venous and intra-articular forms. The hyaluronic acid has various presentations with good analgesic effect and some evidence of structure modifying property. There is IA evidence level for the use of diacerhein and of glucosamine to slow down the disease. Still, more technology for diagnosis and therapy control of OA is necessary to define the efficacy of other drugs. Elsevier 2015-12-06 /pmc/articles/PMC4783603/ /pubmed/26998447 http://dx.doi.org/10.1016/S2255-4971(15)30043-4 Text en © 2009 Sociedade Brasileira de Ortopedia e Traumatologia http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Updating Article de Rezende, Márcia Uchôa Gobbi, Riccardo Gomes DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title | DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title_full | DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title_fullStr | DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title_full_unstemmed | DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title_short | DRUG THERAPY IN KNEE OSTEOARTHROSIS |
title_sort | drug therapy in knee osteoarthrosis |
topic | Updating Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783603/ https://www.ncbi.nlm.nih.gov/pubmed/26998447 http://dx.doi.org/10.1016/S2255-4971(15)30043-4 |
work_keys_str_mv | AT derezendemarciauchoa drugtherapyinkneeosteoarthrosis AT gobbiriccardogomes drugtherapyinkneeosteoarthrosis |